Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Pierre Jean Lamy"'
Autor:
Michel Fabbro, Pierre-Jean Lamy, Célia Touraine, Anne Floquet, Isabelle Ray-Coquard, Caroline Mollevi
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
HE4 and CA-125 are used for epithelial ovarian cancer (EOC) screening, diagnosis, and follow-up. Our objective was to study HE4 and CA-125 kinetics in patients treated for recurrent EOC. Serum samples were prospectively collected before the first che
Externí odkaz:
https://doaj.org/article/37769d66d27546e0a6ad6cc5ca66196e
Autor:
Melissa Sawaya, Emilie Cordina‐Duverger, Pierre‐Jean Lamy, Xavier Rébillard, Brigitte Trétarre, Florence Menegaux
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Introduction Prostate cancer (PCa) is by far the most common type of cancer among men in western countries. However, relatively little is known about its etiology despite the high morbidity and mortality. It has been suggested that chronic i
Externí odkaz:
https://doaj.org/article/59db8439de36487eae85c51d3d4dead5
Autor:
Wendy Bijoux, Emilie Cordina-Duverger, Soumaya Balbolia, Pierre-Jean Lamy, Xavier Rebillard, Brigitte Tretarre, Sylvie Cenee, Florence Menegaux
Publikováno v:
Journal of Occupational Medicine and Toxicology, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background Although prostate cancer (PCa) is the most frequent male cancer in industrialized countries, little is known about its aetiology. The literature has suggested an influence of the environment, including occupational exposures, but
Externí odkaz:
https://doaj.org/article/4215fb40f5764044b9fa777864a3cee1
Autor:
Céline Lavalette, Emilie Cordina Duverger, Fanny Artaud, Xavier Rébillard, Pierre‐Jean Lamy, Brigitte Trétarre, Sylvie Cénée, Florence Menegaux
Publikováno v:
Cancer Medicine, Vol 9, Iss 17, Pp 6421-6429 (2020)
Abstract Elevated body mass index (BMI) has been inconsistently associated with prostate cancer occurrence but it has been suggested that life course adulthood obesity may be associated with an increased risk of prostate cancer. However, few studies
Externí odkaz:
https://doaj.org/article/14ca30dfcc8242a1b7100f20c2d0dbf5
Publikováno v:
Annales de Biologie Clinique. 81:7-23
Autor:
Marie Viala, Akiko Chiba, Simon Thezenas, Laure Delmond, Pierre-Jean Lamy, Sarah L. Mott, Mary C. Schroeder, Alexandra Thomas, William Jacot
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background There has been interest in the potential benefit of vitamin D (VD) to improve breast cancer outcomes. Pre-clinical studies suggest VD enhances chemotherapy-induced cell death. Vitamin D deficiency was associated with not attaining
Externí odkaz:
https://doaj.org/article/c44e02243bd44271820183c3f092b14b
Sleep Patterns and Risk of Prostate Cancer: A Population-Based Case Control Study in France (EPICAP)
Autor:
Emilie Cordina-Duverger, Sylvie Cénée, Brigitte Trétarre, Xavier Rebillard, Pierre-Jean Lamy, Gaelle Wendeu-Foyet, Florence Menegaux
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:2070-2078
Background: Sleep disturbances have been singled out for their implication in the risk of several cancer sites. However, results for prostate cancer are still inconsistent. Methods: We used data from the EPICAP study, a French population-based case
Autor:
Melissa Sawaya, Emilie Cordivadverger, Pierre-Jean Lamy, Xavier Rebillard, Brigitte Tretarre, Florence Menegaux
Publikováno v:
Population Medicine. 5
Autor:
Jérôme Solassol, Thierry Maudelonde, Philippe Rouanet, Pierre-Jean Lamy, Marta Jarlier, Caroline Bascoul-Mollevi, Jérôme Lacombe, Alain Mangé
PDF file - 71K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d04a27127b457b906390fbf6cb2e300
https://doi.org/10.1158/1078-0432.22443161.v1
https://doi.org/10.1158/1078-0432.22443161.v1
Autor:
Jérôme Solassol, Thierry Maudelonde, Philippe Rouanet, Pierre-Jean Lamy, Marta Jarlier, Caroline Bascoul-Mollevi, Jérôme Lacombe, Alain Mangé
Purpose: The identification of markers associated with progression to invasive breast cancer (IBC) is a major factor that can guide physicians in the initial therapeutic decision and the management of ductal carcinoma in situ (DCIS).Experimental Desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0074e26d0fd0cbd5b52bd8245a694e76
https://doi.org/10.1158/1078-0432.c.6519695.v1
https://doi.org/10.1158/1078-0432.c.6519695.v1